CRP and COVID-19: The clinical chemistry data showed a significant elevation of inflammatory biomarkers including C-reactive protein (CRP) and procalcitonin (PCT), but not interleukin 6 (IL-6) in the COVID-19 group compared to the non-COVID-19 group (Table 2).